Matrix proteoglycans: from molecular design to cellular function.

The proteoglycan superfamily now contains more than 30 full-time molecules that fulfill a variety of biological functions. Proteoglycans act as tissue organizers, influence cell growth and the maturation of specialized tissues, play a role as biological filters and modulate growth-factor activities, regulate collagen fibrillogenesis and skin tensile strength, affect tumor cell growth and invasion, and influence corneal transparency and neurite outgrowth. Additional roles, derived from studies of mutant animals, indicate that certain proteoglycans are essential to life whereas others might be redundant. The review focuses on the most recent genetic and molecular biological studies of the matrix proteoglycans, broadly defined as proteoglycans secreted into the pericellular matrix. Special emphasis is placed on the molecular organization of the protein core, the utilization of protein modules, the gene structure and transcriptional control, and the functional roles of the various proteoglycans. When possible, proteoglycans have been grouped into distinct gene families and subfamilies offering a simplified nomenclature based on their protein core design. The structure-function relationship of some paradigmatic proteoglycans is discussed in depth and novel aspects of their biology are examined.

[1]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[2]  A. Imberty,et al.  Carbohydrates and glycoconjugates: Editorial overview , 1999 .

[3]  R. Quatrano Genomics , 1998, Plant Cell.

[4]  R. Iozzo,et al.  Decorin Activates the Epidermal Growth Factor Receptor and Elevates Cytosolic Ca2+ in A431 Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[5]  R. Iozzo,et al.  Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. , 1998, The Journal of clinical investigation.

[6]  G. Yancopoulos,et al.  An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. , 1997, Molecular cell.

[7]  T. Pawson,et al.  The discoidin domain receptor tyrosine kinases are activated by collagen. , 1997, Molecular cell.

[8]  R. Iozzo,et al.  Developmental expression of perlecan during murine embryogenesis , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[9]  S. Stringer,et al.  Specific Binding of the Chemokine Platelet Factor 4 to Heparan Sulfate* , 1997, The Journal of Biological Chemistry.

[10]  E. Gundelfinger,et al.  Sequence and chromosomal localization of the mouse brevican gene. , 1997, Genomics.

[11]  M. Nugent,et al.  Endothelial proteoglycans inhibit bFGF binding and mitogenesis , 1997, Journal of cellular physiology.

[12]  L. Rosenberg,et al.  Characterization of Epiphycan, a Small Proteoglycan with a Leucine-rich Repeat Core Protein* , 1997, The Journal of Biological Chemistry.

[13]  M. Lyon,et al.  The Interaction of the Transforming Growth Factor-βs with Heparin/Heparan Sulfate Is Isoform-specific* , 1997, The Journal of Biological Chemistry.

[14]  B. Calabretta,et al.  Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. , 1997, The Journal of clinical investigation.

[15]  W. Halfter,et al.  Distribution and substrate properties of agrin, a heparan sulfate proteoglycan of developing axonal pathways , 1997, The Journal of comparative neurology.

[16]  H. Kalthoff,et al.  Biglycan gene promoter activity in osteosarcoma cells is regulated by cyclic AMP. , 1997, Biochemical and biophysical research communications.

[17]  N. Grieshaber,et al.  Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells. , 1997, Molecular biology of the cell.

[18]  R. Iozzo,et al.  A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells. , 1997, Cancer research.

[19]  S. Coulter,et al.  A Human-specific Polymorphism in the Coding Region of the Aggrecan Gene , 1997, The Journal of Biological Chemistry.

[20]  E. Schönherr,et al.  Expression of Small Extracellular Chondroitin/Dermatan Sulfate Proteoglycans Is Differentially Regulated in Human Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[21]  M. Ruegg,et al.  Agrin Binds to the Nerve–Muscle Basal Lamina via Laminin , 1997, The Journal of cell biology.

[22]  J. J. Schwartz,et al.  Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? , 1997, The Journal of clinical investigation.

[23]  Y. Kanwar,et al.  Influence of glucose on murine metanephric development and proteoglycans: morphologic and biochemical studies. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[24]  K. Kimata,et al.  Alternative Splicing of the Unique “PLUS” Domain of Chicken PG-M/Versican Is Developmentally Regulated* , 1997, The Journal of Biological Chemistry.

[25]  D. Noonan,et al.  Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA , 1997, Molecular and cellular biology.

[26]  S. Dey,et al.  Expression of heparan sulfate proteoglycan (perlecan) in the mouse blastocyst is regulated during normal and delayed implantation. , 1997, Developmental biology.

[27]  A. Friedl,et al.  Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues. , 1997, The American journal of pathology.

[28]  E. Schönherr,et al.  Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells. , 1997, Archives of biochemistry and biophysics.

[29]  U. Kishore,et al.  Modular organization of carbohydrate recognition domains in animal lectins. , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[30]  A. Malmström,et al.  Cytokine regulation of proteoglycan production in fibroblasts: separate and synergistic effects. , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[31]  P. Underwood,et al.  THE EFFECT OF HUMAN ENDOTHELIAL CELL‐DERIVED PROTEOGLYCANS ON HUMAN SMOOTH MUSCLE CELL GROWTH , 1997, Cell biology international.

[32]  J. Uitto,et al.  Structural and Functional Characterization of the Human Perlecan Gene Promoter , 1997, The Journal of Biological Chemistry.

[33]  J. Hassell,et al.  Identification of Sites in Domain I of Perlecan That Regulate Heparan Sulfate Synthesis* , 1997, The Journal of Biological Chemistry.

[34]  Renato V. Iozzo,et al.  Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, Journal of Cell Biology.

[35]  J. Couchman,et al.  cDNA Cloning of the Basement Membrane Chondroitin Sulfate Proteoglycan Core Protein, Bamacan: A Five Domain Structure Including Coiled-Coil Motifs , 1997, The Journal of cell biology.

[36]  T. Wight,et al.  Selective Expression and Processing of Biglycan during Migration of Bovine Aortic Endothelial Cells , 1997, The Journal of Biological Chemistry.

[37]  A. Barber,et al.  Agrin accumulates in the brain microvascular basal lamina during development of the blood‐brain barrier , 1997 .

[38]  R. Kucherlapati,et al.  Characterization of human DSPG3, a small dermatan sulfate proteoglycan. , 1996, Genomics.

[39]  S. Goodman,et al.  Mouse polymorphonuclear granulocyte binding to extracellular matrix molecules involves β1 integrins , 1996, European journal of immunology.

[40]  M. Rüegg,et al.  Diverse functions of the extracellular matrix molecule agrin , 1996 .

[41]  A. Kumar,et al.  D-glucose-induced dysmorphogenesis of embryonic kidney. , 1996, The Journal of clinical investigation.

[42]  X. Chen,et al.  The gene organization, chromosome location, and expression of a 55-kDa matrix protein (PRELP) of human articular cartilage. , 1996, Genomics.

[43]  E. Hedbom,et al.  Distinct Isoforms of Chicken Decorin Contain Either One or Two Dermatan Sulfate Chains* , 1996, The Journal of Biological Chemistry.

[44]  M. Kunimatsu,et al.  Purification and characterization of perlecan fragment in urine of end-stage renal failure patients. , 1996, Clinica chimica acta; international journal of clinical chemistry.

[45]  C. Peschle,et al.  The Retinoblastoma Family Member p107 Binds to B-MYB and Suppresses Its Autoregulatory Activity* , 1996, The Journal of Biological Chemistry.

[46]  R. Timpl,et al.  Structural characterization of recombinant domain II of the basement membrane proteoglycan perlecan , 1996, FEBS letters.

[47]  S. Grieshaber,et al.  Developmental regulation of perlecan gene expression in aortic smooth muscle cells. , 1996, Matrix biology : journal of the International Society for Matrix Biology.

[48]  T. Sasaki,et al.  Structural and cell-adhesive properties of three recombinant fragments derived from perlecan domain III. , 1996, Matrix biology : journal of the International Society for Matrix Biology.

[49]  U. Greferath,et al.  A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant. , 1996, Development.

[50]  A. Groffen,et al.  Expression and characterization of human perlecan domains I and II synthesized by baculovirus-infected insect cells. , 1996, European journal of biochemistry.

[51]  J. Uitto,et al.  Identification of a Bimodal Regulatory Element Encompassing a Canonical AP-1 Binding Site in the Proximal Promoter Region of the Human Decorin Gene* , 1996, The Journal of Biological Chemistry.

[52]  H. Larjava,et al.  Human Granulation-tissue Fibroblasts Show Enhanced Proteoglycan Gene Expression and Altered Response to TGF-β1 , 1996, Journal of dental research.

[53]  I. Campbell,et al.  Solution Structure of the Link Module: A Hyaluronan-Binding Domain Involved in Extracellular Matrix Stability and Cell Migration , 1996, Cell.

[54]  S. Shapiro,et al.  Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[55]  D. Templeton,et al.  Posttranscriptional effects of glucose on proteoglycan expression in mesangial cells. , 1996, Metabolism: clinical and experimental.

[56]  D. Heinegård,et al.  2B1 antigen characteristically expressed on extracellular matrices of human malignant tumors is a large chondroitin sulfate proteoglycan, PG-M/versican. , 1996, Cancer research.

[57]  Z. Werb,et al.  Decorin regulates collagenase gene expression in fibroblasts adhering to vitronectin. , 1996, Matrix biology : journal of the International Society for Matrix Biology.

[58]  A. Hocking,et al.  Recombinant Decorin Glycoforms , 1996, The Journal of Biological Chemistry.

[59]  K. Oritani,et al.  Identification of stromal cell products that interact with pre-B cells , 1996, The Journal of cell biology.

[60]  D. Birk,et al.  Differential expression of fibromodulin mRNA associated with tendon fibril growth: isolation and characterization of a chicken fibromodulin cDNA. , 1996, The Biochemical journal.

[61]  U. Rauch,et al.  Structural and Electron Microscopic Analysis of Neurocan and Recombinant Neurocan Fragments* , 1996, The Journal of Biological Chemistry.

[62]  J. Scott Proteodermatan and proteokeratan sulfate (decorin, lumican/fibromodulin) proteins are horseshoe shaped. Implications for their interactions with collagen. , 1996, Biochemistry.

[63]  J. Fallon,et al.  Alternative splicing of agrin regulates its binding to heparin alpha-dystroglycan, and the cell surface. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[64]  E. Schleicher,et al.  Glomerular basement membrane-derived perlecan inhibits mesangial cell adhesion to fibronectin. , 1996, European journal of cell biology.

[65]  E. Zycband,et al.  Characterization of collagen fibril segments from chicken embryo cornea, dermis and tendon. , 1996, Matrix biology : journal of the International Society for Matrix Biology.

[66]  P. Maurel,et al.  TAG-1/Axonin-1 Is a High-affinity Ligand of Neurocan, Phosphacan/Protein-tyrosine Phosphatase-ζ/β, and N-CAM* , 1996, The Journal of Biological Chemistry.

[67]  H. Ungefroren,et al.  Transcriptional Regulation of the Human Biglycan Gene* , 1996, The Journal of Biological Chemistry.

[68]  N. Wahab,et al.  Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia. , 1996, The Biochemical journal.

[69]  M. Weber,et al.  Atrial Natriuretic Peptide Inhibits Mitogen-activated Protein Kinase through the Clearance Receptor , 1996, The Journal of Biological Chemistry.

[70]  C. Slater Agrin signals at the junction , 1996, Nature.

[71]  J. Bartek,et al.  The retinoblastoma protein modulates expression of genes coding for diverse classes of proteins including components of the extracellular matrix. , 1996, Oncogene.

[72]  J. Sanes,et al.  Defective Neuromuscular Synaptogenesis in Agrin-Deficient Mutant Mice , 1996, Cell.

[73]  P. Distefano,et al.  Agrin Acts via a MuSK Receptor Complex , 1996, Cell.

[74]  P. Distefano,et al.  The Receptor Tyrosine Kinase MuSK Is Required for Neuromuscular Junction Formation In Vivo , 1996, Cell.

[75]  J. A. Chapman,et al.  Collagen fibril formation. , 1996, The Biochemical journal.

[76]  P. Antonsson,et al.  Amino‐terminal deletions in the decorin core protein leads to the biosynthesis of proteoglycans with shorter glycosaminoglycan chains , 1996, FEBS letters.

[77]  John M. Whitelock,et al.  The Degradation of Human Endothelial Cell-derived Perlecan and Release of Bound Basic Fibroblast Growth Factor by Stromelysin, Collagenase, Plasmin, and Heparanases (*) , 1996, The Journal of Biological Chemistry.

[78]  G. Conrad,et al.  Molecular Cloning and Tissue Distribution of Keratocan , 1996, The Journal of Biological Chemistry.

[79]  J. Couchman,et al.  Perlecan and Basement Membrane-Chondroitin Sulfate Proteoglycan (Bamacan) Are Two Basement Membrane Chondroitin/Dermatan Sulfate Proteoglycans in the Engelbreth-Holm-Swarm Tumor Matrix (*) , 1996, The Journal of Biological Chemistry.

[80]  P. Heitz,et al.  Distribution of the large aggregating proteoglycan versican in adult human tissues. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[81]  Y. Kaneda,et al.  Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney , 1996, Nature Medicine.

[82]  R. Iozzo,et al.  Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[83]  E. Thonar,et al.  Proteoglycans contain a 4.6 A repeat in muscular dystrophy corneas: x-ray diffraction evidence. , 1996, Biophysical journal.

[84]  B. Kasinath,et al.  Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium , 1996, Journal of cellular physiology.

[85]  A. Mccarthy Development , 1996, Current Opinion in Neurobiology.

[86]  P. Maurel,et al.  Chondroitin sulfate proteoglycans in the developing central nervous system. I. Cellular sites of synthesis of neurocan and phosphacan , 1996, The Journal of comparative neurology.

[87]  M. Rüegg Agrin, laminin β2 (s-laminin) and ARIA: their role in neuromuscular development , 1996 .

[88]  M. Mörgelin,et al.  Inhibitory effects of PG‐H/aggrecan and PG‐M/versican on avian neural crest cell migration , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[89]  V. Hascall,et al.  Proteoglycans and proteins in the extracellular matrix of mouse cumulus cell-oocyte complexes. , 1996, Archives of biochemistry and biophysics.

[90]  M. Ruegg,et al.  An amino-terminal extension is required for the secretion of chick agrin and its binding to extracellular matrix , 1995, The Journal of cell biology.

[91]  S. Orkin,et al.  A Functional Initiator Element in the Human β-Globin Promoter (*) , 1995, The Journal of Biological Chemistry.

[92]  K. Watanabe,et al.  cDNA cloning and the identification of an aggrecanase-like cleavage site in rat brevican. , 1995, Biochemical and biophysical research communications.

[93]  C. Garner,et al.  Brevican, a Chondroitin Sulfate Proteoglycan of Rat Brain, Occurs as Secreted and Cell Surface Glycosylphosphatidylinositol-anchored Isoforms (*) , 1995, The Journal of Biological Chemistry.

[94]  E. Ruoslahti,et al.  The versican C-type lectin domain recognizes the adhesion protein tenascin-R. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[95]  K. Danielson,et al.  The murine biglycan: complete cDNA cloning, genomic organization, promoter function, and expression. , 1995, Genomics.

[96]  R. U. Margolis,et al.  Chondroitin Sulfate and Chondroitin/Keratan Sulfate Proteoglycans of Nervous Tissue: Developmental Changes of Neurocan and Phosphacan , 1995, Journal of neurochemistry.

[97]  D. Heinegård,et al.  The Primary Structure of a Basic Leucine-rich Repeat Protein, PRELP, Found in Connective Tissues (*) , 1995, The Journal of Biological Chemistry.

[98]  R. Mason,et al.  Rat mesangial cells in vitro synthesize a spectrum of proteoglycan species including those of the basement membrane and interstitium. , 1995, Kidney international.

[99]  J. Scott,et al.  Extracellular matrix, supramolecular organisation and shape. , 1995, Journal of anatomy.

[100]  J. Korenberg,et al.  The Human Lumican Gene , 1995, The Journal of Biological Chemistry.

[101]  J. Couchman,et al.  Association of versican with dermal matrices and its potential role in hair follicle development and cycling. , 1995, The Journal of investigative dermatology.

[102]  L. Siracusa,et al.  Expression pattern and mapping of the murine versican gene (Cspg2) to chromosome 13. , 1995, Genomics.

[103]  Oldberg,et al.  Decorin-binding Sites for Collagen Type I Are Mainly Located in Leucine-rich Repeats 4-5 (*) , 1995, The Journal of Biological Chemistry.

[104]  A. Ljubimov,et al.  Antibody mapping and tissue localization of globular and cysteine-rich regions of perlecan domain III. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[105]  D. Beier,et al.  Structure and chromosomal localization of the mouse neurocan gene. , 1995, Genomics.

[106]  R. Timpl,et al.  Structural properties of recombinant domain III-3 of perlecan containing a globular domain inserted into an epidermal-growth-factor-like motif. , 1995, European journal of biochemistry.

[107]  L. Vaughan,et al.  Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. , 1995, Development.

[108]  R. Iozzo Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[109]  T Skorski,et al.  De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[110]  J. Cheng,et al.  Structure of the human aggrecan gene: exon-intron organization and association with the protein domains. , 1995, The Biochemical journal.

[111]  W. Halfter,et al.  Identification of a Novel Alternatively Spliced Agrin mRNA That Is Preferentially Expressed in Non-neuronal Cells (*) , 1995, The Journal of Biological Chemistry.

[112]  P. Bork,et al.  The SEA module: A new extracellular domain associated with O‐glycosylation , 1995, Protein science : a publication of the Protein Society.

[113]  R. Stallings,et al.  Primary structure of human lumican (keratan sulfate proteoglycan) and localization of the gene (LUM) to chromosome 12q21.3-q22. , 1995, Genomics.

[114]  K. Kimata,et al.  Molecular cloning of the mouse osteoglycin-encoding gene. , 1995, Gene.

[115]  R. Kokenyesi,et al.  Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells. , 1995, Biochemical and biophysical research communications.

[116]  S. Sugiyama,et al.  Mouse aggrecan, a large cartilage proteoglycan: protein sequence, gene structure and promoter sequence. , 1995, The Biochemical journal.

[117]  J. Marcum,et al.  Distribution of biglycan and its propeptide form in rat and bovine aortic tissue. , 1995, Journal of vascular research.

[118]  J. Uitto,et al.  Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor-alpha , 1995, The Journal of Biological Chemistry.

[119]  F. Maquart,et al.  Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4. , 1995, The Biochemical journal.

[120]  G. Waksman,et al.  FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. , 1995, Science.

[121]  E. Schönherr,et al.  Decorin-Type I Collagen Interaction , 1995, The Journal of Biological Chemistry.

[122]  H. Larjava,et al.  Differential regulation of decorin and biglycan gene expression by dexamethasone and retinoic acid in cultured human skin fibroblasts. , 1995, The Journal of investigative dermatology.

[123]  F. Matsui,et al.  Distribution of a Brain‐specific Proteoglycan, Neurocan, and the Corresponding mRNA During the Formation of Barrels in the Rat Somatosensory Cortex , 1995, The European journal of neuroscience.

[124]  E. Zycband,et al.  Collagen fibrillogenesis in situ: Fibril segments undergo post‐depositional modifications resulting in linear and lateral growth during matrix development , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[125]  W. Halfter,et al.  Agrin Is a Heparan Sulfate Proteoglycan (*) , 1995, The Journal of Biological Chemistry.

[126]  R. Timpl,et al.  Perlecan in human bone marrow: a growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells. , 1995, Matrix biology : journal of the International Society for Matrix Biology.

[127]  G. Laurie,et al.  Recombinant Domain III of Perlecan Promotes Cell Attachment through Its RGDS Sequence (*) , 1995, The Journal of Biological Chemistry.

[128]  D. Zimmermann,et al.  Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. , 1994, The Journal of biological chemistry.

[129]  M. Dours-Zimmermann,et al.  A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. , 1994, The Journal of biological chemistry.

[130]  T Matsumoto,et al.  Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. , 1994, The Journal of biological chemistry.

[131]  A. Yayon,et al.  Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis , 1994, Cell.

[132]  Y. Yamada,et al.  The structure of the rat aggrecan gene and preliminary characterization of its promoter. , 1994, The Journal of biological chemistry.

[133]  R. Iozzo,et al.  Abnormal expression of perlecan proteoglycan in metastatic melanomas. , 1994, Cancer research.

[134]  L. Siracusa,et al.  The murine decorin. Complete cDNA cloning, genomic organization, chromosomal assignment, and expression during organogenesis and tissue differentiation. , 1994, The Journal of biological chemistry.

[135]  K. Ito,et al.  Expression and binding activity of the carboxyl-terminal portion of the core protein of PG-M, a large chondroitin sulfate proteoglycan. , 1994, The Journal of biological chemistry.

[136]  M. Jalkanen,et al.  Function of the syndecans--a family of cell surface proteoglycans. , 1994, Journal of cell science.

[137]  R. Iozzo,et al.  The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. , 1994, The Biochemical journal.

[138]  E. Ruoslahti,et al.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.

[139]  M. Yamagata,et al.  Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. , 1994, Journal of cell science.

[140]  D. Rowe,et al.  Molecular basis of nanomelia, a heritable chondrodystrophy of chicken. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[141]  P. Roughley,et al.  Cartilage proteoglycans: Structure and potential functions , 1994, Microscopy research and technique.

[142]  F. Deák,et al.  Complete coding sequence, deduced primary structure, chromosomal localization, and structural analysis of murine aggrecan. , 1994, Genomics.

[143]  R. Cassingena,et al.  SV40 large-T oncogene inhibits transcription of perlecan-related proteoglycans but stimulates hyaluronan synthesis in a temperature-sensitive renal-tubule principal cell line. , 1994, The Journal of biological chemistry.

[144]  C. Kozak,et al.  Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene , 1994, Nature Genetics.

[145]  M. Fukuda Cell surface and extracellular glycoconjugates , 1994 .

[146]  D. Friedlander,et al.  The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth , 1994, The Journal of cell biology.

[147]  R. U. Margolis,et al.  Interactions with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue. , 1994, The Journal of biological chemistry.

[148]  K Watanabe,et al.  Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. , 1994, The Journal of biological chemistry.

[149]  R. Iozzo Perlecan: a gem of a proteoglycan. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[150]  John,et al.  Basement membrane-specific chondroitin sulfate proteoglycan is abnormally associated with the glomerular capillary basement membrane of diabetic rats. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[151]  D. Volpin,et al.  Identification of a TGF-β Responsive Element in the Human Elastin Promoter , 1994 .

[152]  L. Bruckner-Tuderman,et al.  Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis , 1994, Journal of Cell Biology.

[153]  J. Hassell,et al.  Molecular polymorphism of lumican during corneal development. , 1994, Investigative ophthalmology & visual science.

[154]  R. Iozzo,et al.  Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[155]  R. Iozzo,et al.  Structural and functional characterization of the human decorin gene promoter. A homopurine-homopyrimidine S1 nuclease-sensitive region is involved in transcriptional control. , 1994, The Journal of biological chemistry.

[156]  D. Heinegård,et al.  Binding of fibromodulin and decorin to separate sites on fibrillar collagens. , 1993, The Journal of biological chemistry.

[157]  A. Plaas,et al.  Biosynthetic mechanisms for the addition of polylactosamine to chondrocyte fibromodulin. , 1993, The Journal of biological chemistry.

[158]  E. Edelman,et al.  Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells. , 1993, Circulation research.

[159]  N. Schwartz,et al.  cDNA cloning of chick cartilage chondroitin sulfate (aggrecan) core protein and identification of a stop codon in the aggrecan gene associated with the chondrodystrophy, nanomelia. , 1993, The Journal of biological chemistry.

[160]  R. Pierce,et al.  Alternate exon usage is a commonly used mechanism for increasing coding diversity within genes coding for extracellular matrix proteins. , 1993, Matrix.

[161]  R. Iozzo,et al.  Structural characterization of the complete human perlecan gene and its promoter. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[162]  G. Nicolson,et al.  Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production , 1993, International journal of cancer.

[163]  A. Kikuchi,et al.  Haemopoietic activity associated with biglycan like proteoglycan. , 1993, Biochemical and biophysical research communications.

[164]  D. Heinegård,et al.  Structure and deduced amino acid sequence of the human fibromodulin gene. , 1993, Biochimica et biophysica acta.

[165]  T. Glant,et al.  Expression of alternatively spliced epidermal growth factor-like domains in aggrecans of different species. Evidence for a novel module. , 1993, The Journal of biological chemistry.

[166]  T. Südhof,et al.  Neurexin III alpha: extensive alternative splicing generates membrane-bound and soluble forms. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[167]  K. Ito,et al.  cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican. , 1993, The Journal of biological chemistry.

[168]  G. Conrad,et al.  Sequence and structural implications of a bovine corneal keratan sulfate proteoglycan core protein. Protein 37B represents bovine lumican and proteins 37A and 25 are unique. , 1993, The Journal of biological chemistry.

[169]  J. Hassell,et al.  Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. , 1993, Experimental eye research.

[170]  J. Hassell,et al.  Perlecan gene expression precedes laminin gene expression during differentiation of F9 embryonal carcinoma cells , 1993, Developmental dynamics : an official publication of the American Association of Anatomists.

[171]  R. Timpl,et al.  Mapping of nidogen binding sites for collagen type IV, heparan sulfate proteoglycan, and zinc. , 1993, The Journal of biological chemistry.

[172]  X. Chen,et al.  Assignment of the human aggrecan gene (AGC1) to 15q26 using fluorescence in situ hybridization analysis. , 1993, Genomics.

[173]  S. Nakamura,et al.  Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[174]  P. Roughley,et al.  Versican gene expression in human articular cartilage and comparison of mRNA splicing variation with aggrecan. , 1993, The Biochemical journal.

[175]  R. Butkowski,et al.  Immunochemical and biochemical evidence for distinct basement membrane heparan sulfate proteoglycans. , 1993, The Journal of biological chemistry.

[176]  J. van den Born,et al.  Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. , 1993, Kidney international.

[177]  E. Bonucci,et al.  Localization of bone sialoprotein (BSP) to Golgi and post-Golgi secretory structures in osteoblasts and to discrete sites in early bone matrix. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[178]  R. U. Margolis,et al.  Functional characterization of chondroitin sulfate proteoglycans of brain: interactions with neurons and neural cell adhesion molecules , 1993, The Journal of cell biology.

[179]  M. Iruela-Arispe,et al.  Expression of decorin by sprouting bovine aortic endothelial cells exhibiting angiogenesis in vitro. , 1992, Experimental cell research.

[180]  J. Volanakis,et al.  The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. , 1992, Journal of immunology.

[181]  Vogel Kg,et al.  The effects of transforming growth factor-beta and serum on proteoglycan synthesis by tendon fibrocartilage. , 1992, European journal of cell biology.

[182]  J. McPherson,et al.  Mapping of the versican proteoglycan gene (CSPG2) to the long arm of human chromosome 5 (5q12-5q14). , 1992, Genomics.

[183]  E. Ruoslahti,et al.  Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease , 1992, Nature.

[184]  E. Qwarnstrom,et al.  The role of proteoglycans in cell adhesion, migration and proliferation. , 1992 .

[185]  P. Maurel,et al.  Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain. , 1992, The Journal of biological chemistry.

[186]  M. Linial,et al.  Structure and chromosomal localization of the mammalian agrin gene , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[187]  R. Timpl,et al.  Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core. , 1992, European journal of biochemistry.

[188]  J. Tímár,et al.  Differential expression of proteoglycans on the surface of human melanoma cells characterized by altered experimental metastatic potential. , 1992, The American journal of pathology.

[189]  A. Gressner,et al.  Biglycan and decorin gene expression in normal and fibrotic rat liver: Cellular localization and regulatory factors , 1992, Hepatology.

[190]  M. Rocchi,et al.  Fine mapping of the human biglycan (BGN) gene within the Xq28 region employing a hybrid cell panel. , 1992, Genomics.

[191]  D. Birk,et al.  beta-D xyloside alters dermatan sulfate proteoglycan synthesis and the organization of the developing avian corneal stroma. , 1992, Development.

[192]  J. Turnbull,et al.  Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. , 1992, The Journal of biological chemistry.

[193]  E. Ruoslahti,et al.  Hyaluronate binding properties of versican. , 1992, The Journal of biological chemistry.

[194]  G. R. Dodge,et al.  Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. , 1992, The Journal of biological chemistry.

[195]  H. Olsen,et al.  Transforming growth factor beta 1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene , 1992, Molecular and cellular biology.

[196]  R. Iozzo,et al.  Establishment of a cell line from the EHS tumor: biosynthesis of basement membrane constituents and characterization of a hybrid proteoglycan containing heparan and chondroitin sulfate chains. , 1992, Matrix.

[197]  J. Vergnes,et al.  cDNA to chick lumican (corneal keratan sulfate proteoglycan) reveals homology to the small interstitial proteoglycan gene family and expression in muscle and intestine. , 1992, The Journal of biological chemistry.

[198]  K. Tryggvason,et al.  Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor , 1992, The Journal of cell biology.

[199]  D. Noonan,et al.  The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. , 1991, The Journal of biological chemistry.

[200]  D. Rowe,et al.  Transforming-growth-factor-beta activation elements in the distal promoter regions of the rat alpha 1 type I collagen gene. , 1991, The Biochemical journal.

[201]  J. Esko Genetic analysis of proteoglycan structure, function and metabolism. , 1991, Current opinion in cell biology.

[202]  E. Schönherr,et al.  Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. , 1991, The Journal of biological chemistry.

[203]  M. Young,et al.  Human biglycan gene. Putative promoter, intron-exon junctions, and chromosomal localization. , 1991, The Journal of biological chemistry.

[204]  A. Bassols,et al.  Differential effect of transforming growth factor beta on proteoglycan synthesis in human embryonic lung fibroblasts. , 1991, Biochimica et biophysica acta.

[205]  I. Kovalszky,et al.  Heparan sulfate proteoglycan of human colon: partial molecular cloning, cellular expression, and mapping of the gene (HSPG2) to the short arm of human chromosome 1. , 1991, Genomics.

[206]  B. Olwin,et al.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.

[207]  H. Larjava,et al.  Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. , 1991, The Journal of biological chemistry.

[208]  D. Heinegård,et al.  The synthesis of a family of structurally related proteoglycans in fibroblasts is differently regulated by TFG-beta. , 1991, Matrix.

[209]  T. Imamura,et al.  Contact with basement membrane heparan sulfate enhances the growth of transformed vascular endothelial cells, but suppresses normal cells. , 1991, Cell structure and function.

[210]  R. Ádány,et al.  Hypomethylation of the decorin proteoglycan gene in human colon cancer. , 1991, The Biochemical journal.

[211]  L. Sandell,et al.  Biosynthesis of small proteoglycan II (decorin) by chondrocytes and evidence for a procore protein. , 1991, The Journal of biological chemistry.

[212]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[213]  K. Doege,et al.  Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. , 1991, The Journal of biological chemistry.

[214]  A. Plaas,et al.  Identification of the keratan sulfate attachment sites on bovine fibromodulin. , 1990, The Journal of biological chemistry.

[215]  I. Kovalszky,et al.  Fatty acylation of heparan sulfate proteoglycan from human colon carcinoma cells. , 1990, The Journal of biological chemistry.

[216]  I. Kovalszky,et al.  Transforming growth factor beta alters the expression of heparan sulfate proteoglycan in human colon carcinoma cells. , 1990, The Journal of biological chemistry.

[217]  J. Couchman,et al.  Basement membrane chondroitin sulfate proteoglycans: localization in adult rat tissues. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[218]  R. Ádány,et al.  Altered methylation of versican proteoglycan gene in human colon carcinoma. , 1990, Biochemical and biophysical research communications.

[219]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[220]  R. Ádány,et al.  Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. , 1990, The Journal of biological chemistry.

[221]  J. A. McBain,et al.  Phorbol esters activate proteoglycan metabolism in human colon cancer cells en route to terminal differentiation. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[222]  M. Klemsz,et al.  The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene , 1990, Cell.

[223]  E. Ruoslahti,et al.  Analysis of glycosaminoglycan substitution in decorin by site-directed mutagenesis. , 1990, The Journal of biological chemistry.

[224]  D. Rifkin,et al.  Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. , 1990 .

[225]  O. Mcbride,et al.  Localization of PGI (biglycan, BGN) and PGII (decorin, DCN, PG-40) genes on human chromosomes Xq13-qter and 12q, respectively. , 1990, Genomics.

[226]  S. J. Courtois,et al.  Nuclear factor-I and activator protein-2 bind in a mutually exclusive way to overlapping promoter sequences and trans-activate the human growth hormone gene , 1990, Nucleic Acids Res..

[227]  J. Sanes,et al.  Primary sequence of a motor neuron-selective adhesive site in the synaptic basal lamina protein s-laminin , 1989, Cell.

[228]  E. Ruoslahti,et al.  Multiple domains of the large fibroblast proteoglycan, versican. , 1989, The EMBO journal.

[229]  D. Heinegård,et al.  A collagen‐binding 59‐kd protein (fibromodulin) is structurally related to the small interstitial proteoglycans PG‐S1 and PG‐S2 (decorin). , 1989, The EMBO journal.

[230]  R. Tjian,et al.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. , 1989, Science.

[231]  L. Rosenberg,et al.  The primary structure of the core protein of the small, leucine-rich proteoglycan (PG I) from bovine articular cartilage. , 1989, The Journal of biological chemistry.

[232]  M. Young,et al.  Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. , 1989, The Journal of biological chemistry.

[233]  R. Iozzo Presence of unsulfated heparan chains on the heparan sulfate proteoglycan of human colon carcinoma cells. Implications for heparan sulfate proteoglycan biosynthesis. , 1989, The Journal of biological chemistry.

[234]  R. Iozzo,et al.  Identification of the precursor protein for the heparan sulfate proteoglycan of human colon carcinoma cells and its post-translational modifications. , 1989, Archives of biochemistry and biophysics.

[235]  Y. Courtois,et al.  Specific binding of basic fibroblast growth factor to basement membrane‐like structures and to purified heparan sulfate proteoglycan of the EHS tumor , 1988, Journal of cellular physiology.

[236]  E. Ruoslahti,et al.  Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation , 1988, Nature.

[237]  J. Heino,et al.  Human recombinant interleukin-1 regulates cellular mRNA levels of dermatan sulphate proteoglycan core protein. , 1988, The Biochemical journal.

[238]  D. E. Yorde,et al.  Acetylcholine receptor-aggregating proteins are associated with the extracellular matrix of many tissues in Torpedo , 1988, The Journal of cell biology.

[239]  T. Dexter,et al.  Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis , 1988, Nature.

[240]  M. Sporn,et al.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β , 1988, Cell.

[241]  D. Ingber,et al.  A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. , 1988, The American journal of pathology.

[242]  G. Ruben,et al.  Self-assembly of a high molecular weight basement membrane heparan sulfate proteoglycan into dimers and oligomers. , 1987, The Journal of biological chemistry.

[243]  T. Koob,et al.  Characterization and interactions of a fragment of the core protein of the small proteoglycan (PGII) from bovine tendon. , 1987, Biochemical and biophysical research communications.

[244]  J. Trotter,et al.  The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. , 1987, Collagen and related research.

[245]  E. Ruoslahti,et al.  Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[246]  P. Scott,et al.  A role for disulphide bridges in the protein core in the interaction of proteodermatan sulphate and collagen. , 1986, Biochemical and biophysical research communications.

[247]  R. Iozzo,et al.  Biosynthesis of proteoglycans by rat embryo parietal yolk sacs in organ culture. , 1986, The Journal of biological chemistry.

[248]  R. Timpl,et al.  Immunological characterization of basement membrane types of heparan sulfate proteoglycan. , 1985, The EMBO journal.

[249]  V. Hascall,et al.  Defective processing of keratan sulfate in macular corneal dystrophy. , 1984, The Journal of biological chemistry.

[250]  D. Heinegård,et al.  Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. , 1984, The Biochemical journal.

[251]  H. Kleinman,et al.  Regulation of type I collagen fibril assembly by link protein and proteoglycans. , 1984, Collagen and related research.

[252]  Y. Kanwar,et al.  Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[253]  J. Scott,et al.  Dermatan sulphate-rich proteoglycan associates with rat tail-tendon collagen at the d band in the gap region. , 1981, The Biochemical journal.

[254]  M. Farquhar,et al.  Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion , 1980, The Journal of cell biology.

[255]  A. Clowes,et al.  Suppression by heparin of smooth muscle cell proliferation in injured arteries , 1977, Nature.

[256]  B. Toole Solubility of Collagen Fibrils formed in vitro in the Presence of Sulphated Acid Mucopolysaccharide-protein , 1969, Nature.

[257]  B. Toole,et al.  The effect of chondroitin sulphate-protein on the formation of collagen fibrils in vitro. , 1968, The Biochemical journal.

[258]  A. Horwich,et al.  Structure and function in GroEL-mediated protein folding. , 1998, Annual review of biochemistry.

[259]  M. Carlson,et al.  The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? , 1998, Annual review of biochemistry.

[260]  P. Robbins,et al.  Transporters of nucleotide sugars, ATP, and nucleotide sulfate in the endoplasmic reticulum and Golgi apparatus. , 1998, Annual review of biochemistry.

[261]  E. Cabib,et al.  Role of small G proteins in yeast cell polarization and wall biosynthesis. , 1998, Annual review of biochemistry.

[262]  B. Stillman,et al.  The DNA replication fork in eukaryotic cells. , 1998, Annual review of biochemistry.

[263]  F. Eckstein,et al.  Modified oligonucleotides: synthesis and strategy for users. , 1998, Annual review of biochemistry.

[264]  V. Schramm Enzymatic transition states and transition state analog design. , 1998, Annual review of biochemistry.

[265]  J. Workman,et al.  Alteration of nucleosome structure as a mechanism of transcriptional regulation. , 1998, Annual review of biochemistry.

[266]  M. W. Young The molecular control of circadian behavioral rhythms and their entrainment in Drosophila. , 1998, Annual review of biochemistry.

[267]  R. C. Dickson,et al.  Sphingolipid functions in Saccharomyces cerevisiae: comparison to mammals. , 1998, Annual review of biochemistry.

[268]  A. Frankel,et al.  HIV-1: fifteen proteins and an RNA. , 1998, Annual review of biochemistry.

[269]  H. Lipshitz,et al.  RNA localization in development. , 1998, Annual review of biochemistry.

[270]  I. Mattaj,et al.  Nucleocytoplasmic transport: the soluble phase. , 1998, Annual review of biochemistry.

[271]  N. Pace,et al.  Ribonuclease P: unity and diversity in a tRNA processing ribozyme. , 1998, Annual review of biochemistry.

[272]  R. Iozzo,et al.  The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. , 1997, Critical reviews in biochemistry and molecular biology.

[273]  R. Timpl,et al.  Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides. , 1997, European journal of biochemistry.

[274]  Y. Yamaguchi Brevican: a major proteoglycan in adult brain. , 1996, Perspectives on developmental neurobiology.

[275]  A. Plioplys,et al.  Electron-microscopic investigation of muscle mitochondria in chronic fatigue syndrome. , 1995, Neuropsychobiology.

[276]  P. Roughley,et al.  Changes in the expression of decorin and biglycan in human articular cartilage with age and regulation by TGF-beta. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[277]  R. U. Margolis,et al.  Aggrecan-versican-neurocan family proteoglycans. , 1994, Methods in enzymology.

[278]  D. Noonan,et al.  Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms. , 1993, Kidney international.

[279]  Bostjan Kobe,et al.  Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats , 1993, Nature.

[280]  R. Iozzo,et al.  The human decorin gene: intron-exon organization, discovery of two alternatively spliced exons in the 5' untranslated region, and mapping of the gene to chromosome 12q23. , 1993, Genomics.

[281]  D. Carson,et al.  Heparan sulfate proteoglycan (perlecan) expression by mouse embryos during acquisition of attachment competence. , 1993, Developmental biology.

[282]  A. Woods,et al.  Structure and Biology of Pericellular Proteoglycans , 1993 .

[283]  D. Lane,et al.  Heparin and Related Polysaccharides , 1992, Advances in Experimental Medicine and Biology.

[284]  R. Stevens,et al.  Regulation of the gene that encodes the peptide core of heparin proteoglycan and other proteoglycans that are stored in the secretory granules of hematopoietic cells. , 1992, Advances in experimental medicine and biology.

[285]  A. Plaas Fibromodulin. A Perspective on Function. , 1992 .

[286]  J. Spring,et al.  Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. , 1992, Annual review of cell biology.

[287]  J. van den Born,et al.  A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. , 1992, Kidney international.

[288]  L. Kjellén,et al.  Proteoglycans: structures and interactions. , 1991, Annual review of biochemistry.

[289]  M. Bernfield,et al.  Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation. , 1990, American journal of respiratory cell and molecular biology.

[290]  G. Holmes,et al.  An 8-year experience with depth electrodes in the evaluation of ablative seizure surgery candidates. , 1990, Stereotactic and functional neurosurgery.